Correlation Between MorphoSys and Immuneering Corp

Can any of the company-specific risk be diversified away by investing in both MorphoSys and Immuneering Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MorphoSys and Immuneering Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MorphoSys AG ADR and Immuneering Corp, you can compare the effects of market volatilities on MorphoSys and Immuneering Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MorphoSys with a short position of Immuneering Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of MorphoSys and Immuneering Corp.

Diversification Opportunities for MorphoSys and Immuneering Corp

-0.14

Correlation Coefficient

MorphoSys  Immuneering Corp

Good diversification

The 3 months correlation between MorphoSys and Immuneering is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding MorphoSys AG ADR and Immuneering Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immuneering Corp and MorphoSys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MorphoSys AG ADR are associated (or correlated) with Immuneering Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immuneering Corp has no effect on the direction of MorphoSys i.e., MorphoSys and Immuneering Corp go up and down completely randomly.

Pair Corralation between MorphoSys and Immuneering Corp

Considering the 90-day investment horizon MorphoSys AG ADR is expected to under-perform the Immuneering Corp. In addition to that, MorphoSys is 2.19 times more volatile than Immuneering Corp. It trades about -0.18 of its total potential returns per unit of risk. Immuneering Corp is currently generating about 0.1 per unit of volatility. If you would invest  117.00  in Immuneering Corp on September 29, 2024 and sell it today you would earn a total of  116.00  from holding Immuneering Corp or generate 99.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	22.22%
Values	Daily Returns

MorphoSys AG ADR  vs.  Immuneering Corp

MorphoSys AG ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MorphoSys AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MorphoSys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Immuneering Corp

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Immuneering Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Immuneering Corp is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with MorphoSys and Immuneering Corp

The main advantage of trading using opposite MorphoSys and Immuneering Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MorphoSys position performs unexpectedly, Immuneering Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuneering Corp will offset losses from the drop in Immuneering Corp's long position.

The idea behind MorphoSys AG ADR and Immuneering Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.